Bioventus Improves Product—Ships to Europe

Bioventus, headquartered in Durham, North Carolina, has added new compliance features to its EXOGEN Ultrasound Bone Healing System and has begun shipping in Europe. Company officials say the device will be released in the United States, Canada and Australia later this year. They describe it as being a portable, lightweight device that features an ultrasound probe that patients place on their skin at the site of the bone break for 20 minutes a day. Patients can easily perform the treatment at home, and, they say, EXOGEN has no known contraindications.

The medical device uses safe, low-intensity pulsed ultrasound to help stimulate the body’s natural healing process. Officials claim an 86% heal rate for fractures that are not healing on their own. The new version of EXOGEN introduces new compliance capabilities—such as a log and patient treatment history—to help physicians ensure that patients are appropriately using and benefiting from the device.

“The value of EXOGEN and how it helps fracture patients has long been known and documented, ” explained Duncan Fatkin, vice president of Global Marketing and Reimbursement for Bioventus. “However, patients may not see results unless they adhere to their physician’s prescribed treatment regimen. That’s a theme we heard over and over again as we partnered with physicians, payers and patients to develop the next generation EXOGEN. Achieving better healing outcomes for patients was something they asked us to focus on, and our new features, including the reminder calendar, address this.”

“The acceleration and promotion of bone healing continues to be an important goal in the treatment of fractures, non-unions and limb reconstruction. Research continues but progress is slow and demanding, ” said Gavin De Kiewiet, director of trauma for Limb Reconstruction for Sunderland Royal Hospital in the UK. “The EXOGEN device with low-intensity pulsed ultrasound has greatly contributed to our ability to help these patients, ” he said.